Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001290954 | SCV001479299 | benign | Neurofibromatosis, type 1 | 2020-10-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001290954 | SCV001725934 | benign | Neurofibromatosis, type 1 | 2016-01-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000204434 | SCV001802965 | likely benign | not provided | 2019-08-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001290954 | SCV002560644 | benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004547492 | SCV004734596 | benign | NF1-related disorder | 2020-03-23 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |